|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/00 | |
| A61K 9/20 | |||
| A61K 31/437 | |||
| A61K 33/10 | |||
| A61P 25/20 | |||
| A61K 9/46 | |||
| A61K 47/02 | |||
| A61K 9/50 | |||
| A61K 31/4985 |
| (11) | Patento numeris | 2651391 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11799420.2 |
| Europos patento paraiškos padavimo data | 2011-12-15 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-10-23 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-01-23 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2011/072933 |
| Data | 2011-12-15 |
| (87) | Numeris | WO 2012/080408 |
| Data | 2012-06-21 |
| (30) | Numeris | Data | Šalis |
| 1060655 | 2010-12-16 | FR |
| (72) |
MARTINEZ, Annick, FR
ROUGEOT, Olivier, FR
YAGUCHI, Yoshikatsu, FR
|
| (73) |
SANOFI,
54, rue La Boétie, 75008 Paris,
FR
|
| (54) | PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION INTENDED TO PREVENT MISUSE |
| PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION INTENDED TO PREVENT MISUSE |